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Resumo 
A exposição de organismos aquáticos a vários contaminantes é atualmente 
visto como um problema. Os fármacos são considerados contaminantes 
emergentes e a sua presença tem sido documentada mundialmente, numa 
grande variedade de ecossistemas como rios, estuários e zonas costeiras. 
Estes compostos não são efecientemente eliminados em estações de 
tratamento de águas resíduais, chegando assim aos ecossistemas aquáticos. 
Entre esses compostos, o antidepressivo fluoxetina (FX) e o seu metabólito 
norfluoxetina são comumente detetados em diversos ecossistemas. A FX é 
usada no tratamento de várias doenças do foro psicológico (ex: depressões, 
ansiedade, distúrbio obcessivo-compulsivo e bulímia nervosa), nomeadamente 
em Portugal onde a prevalência de doenças mentais é elevada. A FX é um 
inibidor seletivo de recaptação de serotonina (ISRS) que atua ao nível do 
sistema serotoninérgico do sistema nervoso central, inibindo a recaptação da 
monoamina serotonina (5-HT) ao nível dos seus transportadores (SERT) da 
membrana pré-sináptica, aumentando assim a sua concentração nas fendas 
sinápticas, levando a um aumento da neurotransmissão serotonérgica. Este 
sistema de neurotransmissão é bastante conservado a nível evolutivo e 
portanto é expectável que a FX possa causar efeitos em organismos aquáticos 
expostos. Assim, o estudo tem como objetivo avaliar os efeitos da FX em 
robalos (Dicentrarchus labrax), tanto a nível comportamental como de 
expressão génica. Os juvenis desta espécie ocupam potenciais habitats 
contaminados como estuários e portanto estão sujeitos a exposição. Uma vez 
que o primeiro ano de vida é crucial para as espécies em termos de 
sobrevivência, é importante avaliar as implicações da FX em juvenis de robalo. 
Para isso foi realizado um ensaio de 28 dias: 21 dias de exposição a 
concentrações de 0.5, 5 e 50 µg/ L de FX; mais 7 dias de recuperação. 
Comportamentos considerados relevantes para a espécie como formação de 
cardume, alimentação, velocidade de natação e ansiedade foram avaliados ao 
longo do ensaio. A alimentação foi avaliada através: i) do comportamento 
alimentar; e ii) food intake. A velocidade de natação foi avaliada e calculada 
recorrendo a um dispositivo de velocidade, registando-se o tempo que cada 
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indivíduo demorou a percorrer 3m do dispositivo. A ansiedade foi avaliada a 
partir de: i) posição no aquário; e ii) preferência pela zona escura/ clara 
(Scototaxis) de um dado aquário. O índice hepatossomático (IHS) foi também 
calculado. A expressão de três genes alvo do cérebro (sert; 5-ht3B e mao) foi 
avaliada através do processo real-time quantitative PCR, a partir de amostras 
de cérebro recolhidas ao 21º e 28º dia do ensaio. Os resultados mostram que 
não houve efeito da FX na formação de cardume e na alimentação. O número 
de indivíduos que nadou foi bastante reduzido e portanto não foi possível 
calcular a velocidade de natação, contudo foi observada resistência ao fluxo de 
água o que poderá indicar que os robalos não tinham condição física para 
nadar. A ansiedade verificada a partir da posição no aquário não parece ter 
sido afetada pela FX, no entanto foram observados decréscimos dos níveis de 
ansiedade por scototaxis em todos os grupos expostos o que poderá indiciar 
efeitos ansiolíticos de todas as concentrações de FX. Alterações na expressão 
do gene sert foram observadas no grupo exposto a 50 µg/ L de FX, contudo a 
expressão dos genes 5-ht3B e mao não foi alterada ao longo do ensaio. Em 
conclusão, este estudo demonstrou que a FX pode efetivamente ter efeitos 
tanto a nível comportamental como na expressão génica, e portanto tornasse 
importante verificar até que ponto estas alterações podem por em causa a 
espécie e o seu papel nos ecossistemas que ocupam. 
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Abstract 
The exposure of aquatic organisms to several contaminants is a problem 
and a concern to society. Pharmaceuticals are considered emergent 
contaminants and their presence is well documented worldwide, in a wide 
variety of ecosystems such as rivers, estuaries and coastal areas. Their 
removal in wastewater treatment plants is not fully efficient, thus this 
compounds can reach aquatic ecosystems. Fluoxetine (FX) and their metabolite 
norfluoxetine are antidepressants commonly detected in several ecosystems. 
They are used in the treatment of several mental psychiatric disorders (e.g. 
depressions, anxiety, obsessive compulsive disorders and nervous bulimic), 
namely in Portugal where the prevalence of mental diseases is high. FX is a 
selective serotonin reuptake inhibitor (SSRI) that operates in serotonergic 
system of central nervous system, inhibiting the reuptake of serotonin (5-HT) by 
their transporters (SERT) located in pre-synaptic membrane, leading to an 
increase of the concentration of this monoamine in the synaptic cleft, 
consequently increasing serotonergic neurotransmission. This 
neurotransmission system is well conserved during the evolution so it is 
expected that FX can exert effects on aquatic organisms that are exposed. This 
study aims to evaluate the effects of antidepressant FX in European sea bass 
(Dicentrarchus labrax) behavior and also at the expression of associated 
specific genes in brain (sert; 5-ht3B e mao). Juveniles of this species tend to 
occupy potential contaminated habitats such as estuaries and therefore are 
subject to exposure. Since the first year is the most important in terms of 
survival, it is important to assess the implications that FX might have on the 
species early life. For that purpose a 28 days assay was conducted: i) 21 days 
of exposure to concentrations of 0.5, 5 and 50 µg/ L of FX; plus 7 days of 
recovery. Relevant behaviors such as shoaling, feeding, swimming velocity and 
anxiety were evaluated during the assay. Feeding was evaluated by: i) feeding 
behavior; and ii) food intake. Swimming velocity was evaluated and calculated 
using a raceway, registering the time each individual took to swim through 3m 
of the device. Anxiety was evaluated by: i) position on the aquarium; and ii) 
dark/ light compartment preference (scototaxis). Hepatosomatic index (HSI) 
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was also calculated. Gene expression was evaluated with brain samples from 
day 21 and 28, through real-time quantitative PCR. Results showed that FX did 
not exert any effect on shoaling and feeding. Swimming velocity was not 
calculated due to the small number of fishes that swam, however flow 
resistance was observed which can indicate that sea bass juveniles were not in 
good shape to swim. Anxiety through position on the aquarium wasn't affected 
by FX, nonetheless a decrease in anxiety levels of all exposed groups was 
observed by scototaxis, which can indicate potential anxiolytic effects of FX. 
Alterations on the expression of gene sert were registered at the concentration 
of 50 µg/ L of FX, however the expression of genes 5-ht3B and mao wasn't 
altered during the assay. In conclusion, this study demonstrated that FX can 
affect the behavior and gene expression of European sea bass, so it is 
important to evaluate the extension of this problem to the species and their 
specific role in their ecosystems. 
 
Keywords 
Antidepressant; fluoxetine; European sea bass; behavior; gene expression. 
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Chapter 1. Introduction 
1. Fluoxetine 
Recent studies have shown the presence of pharmaceuticals and personal 
care products in the environment (Daughton and Ternes, 1999; Boyd et al., 
2003; Blair et al., 2013). Pharmaceuticals, which are used for human and 
veterinary purposes are considered emerging contaminants in the environment 
(Fent et al., 2006). Several pharmaceuticals and their metabolites are found in 
aquatic ecosystems (Boyd et al., 2003; Santos et al., 2013; Lajeunesse et al., 
2011), such as rivers (Fent et al., 2006; Alonso et al., 2010), estuaries (Calamari 
et al., 2003; Thomas and Hilton, 2004; Fent et al., 2006; Birch et al., 2015), 
lakes (Blair et al., 2013) and coastal areas (Munaron et al., 2012). 
Pharmaceuticals and their metabolites are excreted after their utilization, 
reaching aquatic ecosystems by several pathways, like urban sewages or 
hospital wastewaters. Their removal in wastewater treatment plants (WWTPs) is 
not fully efficient, making them together with effluents, one of the main pathways 
of contamination of the environment (Fent et al., 2006; Kreke and Dietrich, 2008; 
Santos et al., 2013). Some of these compounds remain bioactive in the 
environment, liable to bioaccumulate and exert toxic effects on aquatic and 
terrestrial organisms, highlighting their role as contaminants with potential risks 
at short and long-term to the aquatic ecosystems (Fent et al., 2006; Kreke and 
Dietrich, 2008; Corcoran et al., 2010). Within the pharmaceuticals found in the 
environment there are several groups such as analgesics, psychotropic drugs, 
antibiotics, β-blockers and anti-inflammatory (Fent et al., 2006; Santos et al., 
2013). Pharmaceutical targets such as receptors, neurotransmission systems, 
biochemical pathways and enzymes are conserved in evolutionary terms, 
therefore it is expected that their presence might affect organisms exposed 
reinforcing the need to study their effects and impacts to the non-target species 
(Fent et al., 2006; Kostich and Lazorchak, 2007; Santos et al., 2013). 
Within the psychotropic drugs antidepressants are used worldwide, 
particularly in OECD countries of which Portugal is a member (OECD health 
data, 2011; Infarmed, 2013). Portugal has the highest rates of use of 
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antidepressants in the European Union, where the prevalence of use is the 
double of the average of EU (Eurobarometer, 2010). Antidepressants are 
prescribed for the treatment of depressions and other psychiatric disorders such 
as anxiety, eating and obsessive-compulsive disorders, and others (Brooks et 
al., 2003; Kreke and Dietrich, 2008; Valenti et al., 2012; Auclair et al., 2013). 
Selective serotonin reuptake inhibitors (SSRI) are a group of antidepressants 
that act in the serotoninergic system of the central nervous system (CNS) by 
inhibiting the reuptake of serotonin (5-HT) by their transporters (SERT) in the 
presynaptic membrane, thereby increasing the concentration of 5-HT in the 
synaptic clefts, therefore increasing serotoninergic neurotransmission (Nutt et 
al., 1999; Kreke and Dietrich, 2008; Valenti et al., 2012) (Figure 1). In order to 
achieve the desired pharmacological effects of SSRI in human patients it is 
necessary a chronic treatment. Likely, this may occur due to alterations in SERT 
gene expression levels and not to a direct inhibition of SERT action (Kreke and 
Dietrich, 2008). There are some evidences that SSRI have potential drug-drug 
interaction with other classes of pharmaceuticals (Hiemke and Hartter, 2000). 
Differences in pharmacology of SSRI in terms of selectivity, chemical structure, 
receptor binding and pharmacokinetic properties should also be considered in 
the treatment of psychiatric disorders (Nutt et al., 1999; Carrasco and Sandner, 
2005; Kreke and Dietrich, 2008).  
 
Figure 1: Pharmacological mode of action of the SSRI (Adapted from Pharmacology corner, 2014). 
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Recently, the organization of 5-HT neuronal network in fishes has been 
investigated and several proteins (e.g. enzymes, metabolites, receptors, 
transporters) involved in serotoninergic system, already known in mammals 
have also been identified in fishes (Kreke and Dietrich, 2008). Catabolic enzyme 
monoamine oxidase (MAO) has been found in several fish species, such as 
goldfish (Carassius auratus) (Hall and Urueña, 1982), rainbow trout 
(Oncorhynchus mykiss) (Hall et al., 1986), pike (Esox lucius) (Senatori et al., 
1990) and zebrafish (Danio rerio) (Setini et al., 2005; Sallinen et al., 2009; 
Aldeco et al., 2011). Contrary to mammals, who have two MAO's (Type A and 
B), in fishes only one MAO have been detected (Senatori et al., 1990; Lillesaar 
et al., 2011). This MAO is described as been different from both MAO A and 
MAO B (Senatori et al., 2003), however some evidences suggested that there 
are similarities in terms of pharmacology and structure namely MAO A (Setini et 
al., 2005). The presence of 5-HT receptors has also been identified in several 
teleostei species (Yamaguchi and Brenner, 1997; Clotfelter et al., 2007; Kreke 
and Dietrich, 2008; Maceira et al., 2014). 5-HT1 receptor genes were identified 
in puffer fish (Fugu rubripes), and when in comparison with the same human 
gene, some similarities were determined, namely all essential amino acid 
residues present in their homologues. However, evidence showed the presence 
of additional phosphorylation sites in puffer 5-HT1 receptors, which suggests that 
their regulation could be different from the human gene (Yamaguchi and 
Brenner, 1997). Experiments in rainbow trout showed that 5-HT2C receptors are 
involved in the mediation of inhibition of food intake induced by 5-HT. These 
results are consistent with the fact that the role of this receptor is preserved 
during the evolution vertebrates. It has been proposed that in mammals the 
inhibitory effects on food intake induced by the activation of 5-HT2C receptors 
are mediated by activation of the melanocortin pathway, so if the functions of the 
receptor are preserved it is hypothesized that in fishes the processes are 
similar, and also induces anorexigenics effects (Maceira et al., 2014). In 
zebrafish, it was demonstrated that amino acid sequences of transporter serta 
and sertb are 66-69% and 75%, respectively, similar to other vertebrates (Wang 
et al., 2006). Hence, there are several evidences about the conservation of 
SERT in animal phyla (Cavaney et al., 2006) nevertheless the regulation and 
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properties of the transporter protein may be diverse in non target species (Kreke 
and Dietrich, 2008). Antidepressants are detected in the environment at several 
concentrations, ranging from ng/ L to μg/ L (Metcalfe et al., 2003; Fent et al., 
2006; Vasskog et al., 2006; Kreke and Dietrich, 2008; Schultz and Furlong, 
2008; Santos et al., 2013; Silva et al., 2014). Several SSRIs such as fluoxetine 
(FX) and sertraline (SER) and their metabolites norfluoxetine (NFX) and 
desmethylsertraline respectively, citalopram, fluvoxamine (FLV) and paroxetine 
(PAR) have been documented in the environment and also in animal tissues 
(Brooks et al., 2003; Metcalfe et al., 2003; Brooks et al., 2005; Fent et al., 2006; 
Kreke and Dietrich, 2008; Patterson and Metcalfe, 2008; Santos et al., 2013; 
Silva et al., 2014). Several studies have already reported the presence of FX in 
WWTPs. For example, the WWTPs of the lower Great Lakes of Canada with FX 
concentrations between 0.038 ± 0.003 μg/L and  0.099 ± 0.007 μg/L, (Metcalfe 
et al., 2003). FX was also detected in TronsØ, Norway in SjØlund pump station 
at 2.3 ng/L, and in three STPs, Lagnes, Breivika and Hamna at 0.4, 125 ± 0.07 
and 1.85 ± 0.78 ng/L (Vasskog et al., 2006). FX and its metabolite NFX were 
detected at ranges of 33 - 49 and 3-7 ng/L respectively, in a downstream from 
the Pecan Creek Water Reclamation Plant (Denton, Texas, United States of 
America) (Schultz and Furlong, 2008). In Portugal, FX was also detected during 
the autumn in 15 WWTPs of the North, Center, Lisbon and Tagus Valley, 
Alentejo and Algarve, at ranges of 105.80 - 157.40 ng/L in wastewater influents 
(Silva et al., 2014). Contrary to others SSRIs, FX is a potent inhibitor of 5-HT2A 
and 5-HT2C, modulating norepinephrine and dopamine systems in brain, 
consequently causing weight loss and activation. When compared with other 
SSRIs, FX has a largest volume of distribution (up to 100 L/kg body weight) 
which indicates extensive tissue accumulation. Pharmacological half-life (t1/2) of 
FX ranges 1-4 days. Due to FX high volume of distribution together with their 
high t1/2, treatments of 1-22 months are required in order to achieve steady-state 
conditions in human patients (Kreke and Dietrich, 2008).  
Alterations in the neuro-endocrine system (Menningen et al., 2011), glucose 
metabolism and weight loss (Menningen et al., 2010) were registered in goldfish 
after the exposition to FX. Changes in the egg production were detected in 
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zebrafish after exposure to FX (Lister et al., 2009). Behavioral changes were 
also reported after exposition to FX, in the decrease of swimming velocity of 
sheepshead minnow (Cyprinodon variegates) (Winder et al., 2011) and hybrid 
striped bass (Morone saxatilis x M. chrysops) (Gaworecki and Klaine, 2008). 
Anxiety changes were also reported in zebrafish chronically exposed to FX 
(Egan et al., 2009). Mianserin, another antidepressant acts as neuroendocrine 
disruptor in zebrafish (van der Ven et al., 2006).  
 
2. European sea bass 
The European sea bass Dicentrarchus labrax (Figure 2) belongs to the 
order of Perciformes and the family Moronidae and has a distribution range 
along the northeast coast  of Atlantic ocean, from Norway to Senegal and from 
Mediterranean sea to Black sea (Kottelat and Freyhof, 2007) (Figure 3). In 
Portugal, this species is commonly observed throughout the Portuguese coast 
(Vasconcelos et al., 2010) and a typical user. European sea bass is a predator 
and their diet varies throughout its ontogeny, being in the juvenile phase 
essentially composed by benthic macroinvertebrates and gradually being 
replaced by major invertebrates and other fishes (Kottelat and Freyhof, 2010). 
Juveniles tend to shoal and habitat estuarine ecosystems that function as 
nursery habitats (Vasconcelos et al., 2010). European sea bass is a species of 
human consumption, being captured by professional fisheries and also 
cultivated in aquaculture systems.  In Portugal, it is not amongst the most fished 
species, however is one of the most produced species in aquaculture (INE, 
2015), making the species a source of socio-economical value. The occurrence 
of this species in habitats potentially contaminated by antidepressants as 
estuaries, make them vulnerable to antidepressants and other pharmaceuticals, 
what can ultimately lead to exposure of human to these pollutants (Fent et al., 
2006; Kreke and Dietrich, 2008; Lajeunesse et al., 2011; De Domenico, et al., 
2013). Thus, it is urgent to assess the impacts of such contaminants in 
European Sea Bass, assessing not only the environmental but also the human 
risks associated.  
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Figure 2: European sea bass juvenile specimen. 
 
 
Figure 3: Geographical distribution of European sea bass.  
 
3. Objectives 
This study aims to evaluate the effect, at the behavioural level and 
neuroendocrine disruption, of the exposure to an SSRI (FX) on juvenile 
European sea bass. Behavioral alterations are important as they can interfere 
with several actions of the individuals (alimentation, reproduction, refugee, 
movement and migrations), consequently affecting the population dynamics. 
Behavioural associated effects will be evaluated based on swimming velocity, 
anxiety and food intake. Alterations in gene expression of components of the 
serotinegic system can provide further information on the neuroendocrine 
disruption potential of SSRI and also explain physiological alterations leading to  
behavioral changes. 
©Aquamaps.org 
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1. Abstract 
Recently, the presence of several pharmaceuticals as antidepressant (FX) 
and their metabolites has been documented in aquatic ecosystems. FX is a 
selective serotonin reuptake inhibitor (SSRI) that operates in the serotonergic 
system of the central nervous system. These compounds are not always 
eliminated in wastewater treatment plants, reaching aquatic ecosystems as 
rivers and estuaries. This study aims to evaluate the effect of FX exposure on 
European sea bass (Dicentrarchus labrax) juveniles at behavior level and also 
at the expression of associated specific brain genes. For this purpose, an 
exposure assay of 21 days plus 7 days of recovery was conducted. Several 
behaviors such as shoaling, feeding (behavior and food intake), swimming 
velocity and anxiety (position on the aquarium and scototaxis), were evaluated 
during the assay to assess deviants to the normal parameters. The expression 
of three associated genes was also evaluated with brain tissue samples 
collected at 21th and 28th day. Results showed that FX did not exert any effect 
on shoaling and in feeding. FX effects on swimming velocity were not able to 
assess due the small number of individuals that swam, nonetheless flow 
resistance behavior was observed however with no apparent pattern. Anxiolytic 
effects of FX were observed on scototaxis tests, since there was a decrease of 
anxiety levels in exposed fishes, nonetheless no effects were observed in the 
preference for  a specific position on the aquarium. The expression of gene sert 
appears to be altered by the exposition to high concentrations of FX, however 
no large differences were observed in the expression of the other two genes, 5-
ht3B and mao. 
 
2. Introduction 
Recent studies demonstrate the presence of pharmaceutical and personal 
care products in the environment (Boyd et al., 2003; Ellis, 2006; Salgado et al., 
2010; Blair et al., 2013). Several pharmaceuticals, as antidepressants and their 
metabolites are found in aquatic ecosystems (Boyd et al., 2003; Santos et al., 
2013; Lajeunesse et al., 2011) and wastewater treatment plants (WWTPs) at 
several concentrations, ranging from ng/ L to μg/ L (Fent et al., 2006; Kreke and 
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Dietrich, 2008; Santos et al., 2013). WWTPs are not efficient in the removal of 
pharmaceuticals, which makes them together with effluents one of the main 
pathways of contamination of the environment (Fent et al., 2006; Kreke and 
Dietrich, 2008; Santos et al., 2013). The targets sites of these compounds are 
evolutionary well conserved (e.g. metabolic pathways, neurotransmission 
systems, etc). Moreover, some of these compounds remain bioactive in the 
environment, liable to bioaccumulate and exert toxic effects on ecosystems, 
therefore they considered emerging contaminants with potential risks to aquatic 
ecosystems not only on a short but also long-term scale (Fent et al., 2006; 
Kreke and Dietrich, 2008; Corcoran et al., 2010). 
FX is a SSRI antidepressant considered an emergent contaminant, and its 
presence is well documented in several ecosystems (Metcalfe et al., 2003; 
Schultz and Furlong, 2008) and WWTPs (Silva et al., 2014). FX acts in the 
serotonergic system of the central nervous system by inhibiting the reuptake of 
serotonin (5-HT) by their transporters (SERT) in the pre-synaptic membrane, 
thereby increasing the concentration of 5-HT in the synaptic clefts and therefore 
increasing serotonergic neurotransmission (Nutt et al., 1999; Kreke and 
Dietrich, 2008; Valenti et al., 2012). FX can also modulate norepinephrine and 
dopamine systems in brain by inhibiting 5-HT2A and 5-HT2C (Nutt et al., 1999; 
Carrasco and Sandner, 2005).) Several studies have been conducted to assess 
the effects of these compounds in different fish species. Anxiety changes were 
reported in zebrafish Danio rerio after chronic exposure to FX (Egan et al., 
2009). Sheepshead minnow Cyprinodon variegatus (Winder et al., 2011) and 
hybrid striped bass Morone saxatilis x M. chrysops (Gaworecki and Klaine, 
2008) when exposed to FX decreased their swimming velocity. Also, neuro-
endocrine alterations (Menningen et al., 2011), glucose metabolism changes 
and weight loss (Menningen et al,, 2010) were reported in goldfish Carassius 
auratus. 
Estuaries are worldwide acknowledged as important aquatic ecosystems, 
suffering the impacts of the many human activities that can compromise their 
ecological function and threat their long-term viability. Estuaries have become 
reservoirs of emergent contaminants that can threat not only the individual 
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organisms exposed but also the ecological functioning of the ecosystem. 
European sea bass (Dicentrarchus labrax) is a marine species that commonly 
uses estuaries as feeding areas and also as nursery habitat for juveniles 
(Vasconcelos et al., 2010). This species with high socio-economic value can be 
endangered by the exposition to emerging contaminants as antidepressant 
fluoxetine. Thus, this species was selected as the model to evaluate the 
environmental risk of antidepressant pharmaceutical pollutants, due to their 
important role in their ecosystems low maintenance cost in the laboratory and 
the good response in behavioral terms when exposed to pollutants (Almeida et 
al., 2010).  
The present study aims to evaluate the effect of the exposure to FX on 
juvenile European seabass  by assessing (i) behavior (swimming velocity, 
anxiety and food intake) and (ii) the expression of genes codifying for 
components of the serotonergic system in brain. The behavioral alterations are 
important as they can interfere with several actions of the individuals (feeding, 
reproduction, refugee, movement and migrations), consequently affecting the 
population dynamics, what is particularly important for commercially exploited 
species as the European sea bass. 
 
3. Material and methods 
3.1. Animals used  
European sea bass juveniles were provided by Tinamenor aquaculture, 
Santander, Spain. The animals were maintained under conditions of water 
recirculation in a 2200L tank and a photoperiod of 12: 12 hours (light: dark). The 
tank was regularly monitored in order to maintain constant seawater levels of 35 
ppm), 13-14 ºC, 7.5-8.0 pH, and ammonia and nitrites levels under 0.5 mg/ mL. 
Water exchanges were made in order to avoid water quality deterioration. 
Gradually, the water salinity was being decreased until 25 ppm, in order to cope 
with the assay requirements. Animals were fed three days a week with 
commercial pellets of granulometry 4mm. 
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3.2. Experimental assay 
The experimental assay included five groups in triplicate namely: control (Ct), 
control solvent (0.01% dimethyl sulfoxide) (CtS) and three concentrations of FX 
(0.5, 5 and 50 µg/L) (Figure 4). A total of 120 individuals (11.11 ± 0.67 cm total 
length and 11.05 ± 2.38 g total weight) were used and distributed by 15 
aquariums of 30 L (with 23 L of water), in a total of 8 individuals per aquarium. 
The experimental assay was made in a semi-static system with daily 80% of 
water changed durating the 21 days of exposure to FX plus 7 days of recovery 
with no chemicals added. The aquariums were kept under conditions of salinity 
of 25 ppm, temperature range of 17-19º C, pH ≈ 6 and photoperiod of 12:12 
hours (light: dark).  
 
Figure 4: Scheme of the experimental assay. * Aquariums used for the raceway tests; ** aquariums used for scototaxis 
tests. 
 
3.3. Behavior evaluation 
Sea bass behavior evaluation wasn't uniform. Shoaling and position on 
aquarium was observed twice a day (10-12 a.m. and 15-17 p.m.). Feeding 
behavior and food intake were evaluated every two days, according to the days 
where fishes were fed. Swimming velocity and scototaxis tests were done at 
several points of interest during the assay: i) exposure period (day 1, 3, 7, 15 
and 21); and ii) recovery (day 28). 
Shoaling is considered the regular behavior of European sea bass juveniles 
(Vasconcelos et al., 2010) and in order to evaluate potential alterations, the 
number of isolated fishes was registered. For this behavior the following criteria 
was used: 1 - less than 3 fishes (<37.5%); 2 - three to five fishes (37.5% - 
62.5%); and 3 - more than five fishes (>67.5%), considering a total of 8 fishes 
per aquarium.  
FX0.5 FX50 Ct FX5 CtS FX50 Ct CtS FX0.5 FX50 Ct CtS FX5 FX0.5 FX5
* * ********* * * **
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Feeding started at the third day of the assay. Feeding behavior was observed 
during the moments where sea bass juveniles were fed. For that purpose the 
following criteria was used in order qualify the reaction to pellets: 1 - 
indifference (when fishes don't react to pellet), 2 - timidity (fishes react 
cautiously to pellet); and 3 - voracious (fishes reacts immediately to pellet). 
Food intake was also evaluated at the same periods of time. Animals were 
provided with 2% of the total fish weight in each aquarium. Half an hour after 
feeding, the remaining pellet was collected and dried in a oven until the weight 
remained stable. This weight permits to calculate the exact amount of food that 
was not eaten, and therefore quantify the food intake of each aquarium. 
A 4 m raceway device (Figure I in Annex) was used to assess alterations of 
the swimming velocity in European sea bass exposed to FX. Prior to the 
beginning of the assay, all conditions of the raceway were tested and calibrated 
in order to establish the best conditions for the test (Protocol I in Annex). Each 
animal was placed in the same position of the raceway device to swim against 
a counter current flow of 6 L/ min. The time (in seconds) that each individual 
took to swam 3 m of the raceway was registered and the swimming velocity 
was calculated as the quotient of the distance and the time to reach 3m race. 
When fishes did not swam and stayed in the initial position resisting the water 
flow, this time was also registered for a maximum of sixty seconds (Gravato 
and Guilhermino, 2009; Almeida et al., 2010; Almeida et al., 2012) and use to 
estimate the flow resistance as indicator of a deviant behavior. Handling of fish 
can cause stress and therefore physiological alterations (Pickering et al., 1982; 
Barton, 2000), however it is unavoidable in this test. Giving the short time of 
handling process possible effects will be acute (Pickering et al., 1982); so in 
order to minimize stress, fishes only relayed a maximum of sixty seconds in the 
raceway device. 
The number of individuals that occupied the top and bottom of the aquarium 
were observed separately, following the same criteria used for shoaling 
observations. European sea bass juveniles exhibit demersal behavior 
(Barnabé, 1989) and therefore tend to occupy the center and the bottom of the 
aquarium to imitate their natural environment. So, the preference for upper 
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regions of the aquarium was used as proxy of low anxiety levels (Gaworecki 
and Klane, 2008; Egan et al., 2009). Scototaxis (dark/ light preference) was 
used to assess the anxiety of European sea bass juveniles. For that purpose a 
specific device was mounted using an aquarium of 70L divided in three zones, 
colorless central zone, a black and a white compartment and filled with 30L of 
water from the system (Figure II in Annex). Similarly to raceway experiment, 
previous tests were made in order to test the best conditions to perform the 
experiment (Protocol II in Annex). Each individual was placed in the central 
zone of the aquarium and its preference was registered (Maximino et al., 2010; 
Maximino et al., 2011; Brandão et al., 2013), considering the preference for 
black compartment as proxy of anxiety. 
 
3.4. Biological samplings 
Biological sampling was done at 21th and 28th day of the assay. Animals 
were anesthetized with MS222 (0.25%) and sacrificed according to the 3R's 
policy, and weight and length (total and standard) were measured. Liver was 
also removed and weighted in order to calculate hepatosomatic index (liver 
weight (g)/ fish weight (g) x100). Brain samples were collected and stored in 
RNAlater at -80º C, in order preserve the tissues for molecular analysis.  
 
3.5. RNA extraction and cDNA synthesis 
Total RNA was extracted from the RNAlater stored brain samples using   the 
Illustra RNAspin Mini Kit (GE Healthcare) according to the manufacturer 
protocol. Them, RNA was purified with DNase I from the same kit in order to 
clean DNA remains that could possible contaminate our samples. RNA quality 
was verified by electrophoresis in agarose by gel red stains and by the 
measurement of the ratio of optical density  λ260/ λ280 nm. RNA was quantified 
and diluted to 1 µg (Pfaffl, 2001). After, RNA was used as template to 
synthesize cDNA with qScript cDNA SuperMix (Quanta Biosciences). 
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3.6. Quantitative real-time PCR 
Gene expression of sert, 5-ht3B, mao, ef1, l17 and 18s was assessed by 
means of quantitative real time PCR (qRT-PCR) (Table 1). qRT-PCR was 
performed in a Eppendorf Realplex 4, and for the purpose a mix contain 10 µl of 
SYBR Green fluorescence Supermix (Quanta Biosciences), 2 µl of each primer 
reverse and forward (Concentration of 3 nM) and 2 µl of cDNA in a total volume 
of 20 µl in duplicate. Reactions for qRT-PCR  were conducted following 
protocol: denaturation program (94ºC for 2min), amplification and quantification 
program repeated 40 times (94ºC for 30s, 55ºC for 30s, 72ºC for 30s and 72ºC 
for 10min)and a melting curve program (from 55 to 95º C)to determine the 
formation of the specific products. When the reaction was over, we proceed to 
the analysis and the values of crossing points (CP) and melting temperature 
(TM) were recorded in a database intended for statistical analysis. CP is defined 
as the point at which the fluorescence rises appreciably above the background. 
The formation of PCR products is responsible for this increase and therefore  
it's important to know the cycle where this begins (Pfaffl, 2001). Gene 
expression was quantified by normalization with multiple references genes 
using Normfinder algorithm (Urbatzka et al., 2013) For characterization of the 
transcription profile elongation 18s and ef1 were used as reference genes. For 
the determination of the relative quantification of the target genes in comparison 
to reference genes we used the relative expression ratio equation (Pfaffl, 2001): 
                            ratio=(Etarget)
ΔCP 
target
(control-sample) 
                                     (Eref)
 ΔCP
ref
(control-sample) 
This equation is a mathematical model of relative expression ratio in qRT-
PCR, where the ratio of the target genes is expressed in a sample versus a 
control in comparison to reference genes. Ratio allows to assess physiological 
changes in gene expression (Pfaffl, 2001). The variables of this equation are: 
E
target is the qRT-PCR efficiency of the target gene transcript; 
E
ref is the qRT-PCR 
efficiency of the reference genes transcript; ΔCP target is the CP deviation of 
control-sample of the target gene transcript and ΔCPref is the CP deviation of 
control-sample of the reference genes transcript. As reference genes we used 
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housekeeping genes due to their stability and secure unregulated transcript 
(Pfaffl, 2001). 
Table 1: Selected genes for the RT-qPCR. Product (bp) and Efficiency of PCR reaction. 
Gene (Acession number) Primer sequence (5'-3') 
Product 
(bp) 
Efficiency 
(%) 
sert (002060) 
F GTTGATGGCAGTGTTTGGTG 
109 92 
R GAAGATGGGGCAGATGTGTT 
5-ht3B (00046560) 
F TCATCTGGCTGAATGTGTGC 
91 100 
R AACTCCGCAGTCGTATTTCC 
mao (00018080) 
F GCCAATCACCTCAACCAAAC 
100 104 
R AGGGACAAACCAAACACTGG 
 
 
3.7. Data analysis 
All data was averaged by day and group (mean ± standard deviation) with 
the exception of anxiety, where results are given in frequencies. Shoaling, 
feeding and position on the aquarium data were aggregated into three different 
periods of the assay: i) short exposure (day 2 to 9); ii) long exposure (day 10 to 
day 20); and recovery (day 22 to 28). Flow resistance and anxiety were 
analyzed in several days of two periods: i) exposure (day 1, 3, 7, 15 and 21); 
and ii) recovery (day 28). HSI and gene expression data was analyzed in two 
different periods: 21th day (end of exposure); and 28th day (end of recovery). 
Differences in food intake, HSI and three target genes expression between 
concentration  groups and during the time of the assay were investigated by 
two.way analysis of variance (ANOVA) with concentration and time as fixed 
factors (Zar, 1996). Gene expression data were log transformed in order to 
stabilize the variance and to fit data to a normal distribution, fulfilling one of the 
ANOVA assumptions. Homogeneity of variance was tested with a Cochran test 
and whenever variance was still  heterogeneous, conclusions from ANOVA 
results were only accepted for those cases where significance levels were less 
than 0.01. Furthermore, in the event of significance, an a posteriori Tukey HSD 
for unequal sample sizes was used to determine which means were significantly 
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different at a 0.05 level of probability (Spjotvoll and Stoline, 1973). All analyses 
were performed using the software STATISTICA version 12. 
 
3.8. Ethical statement 
The animals were treated in accordance with the Portuguese Animals and 
Welfare Law (Decreto-Lei no 197/96) approved by the Portuguese Parliament in 
1996 and with the European directive 2010/63/UE approved by the European 
Parliament in 2010. 
 
4. Results 
4.1. Behavior results 
According to the shoaling results, in average less than 3 fishes in a total of 8 
fishes per aquarium (criteria 1) were isolated in the aquarium (Figure 5). Such 
pattern was systematically registered for all five groups of treatments and 
throughout the duration of the assay, without alterations in the recuperation 
period. Results showed that there were no alterations to the typical shoaling 
behavior of juvenile sea bass during the assay. 
 
Figure 5: Number of solitary juvenile sea bass observed in each aquarium divided by group during three periods 
(short, long and recovery) of the assay. Criteria used: 1 - less than three fishes; 2 - three to five fishes; and 3 - more 
than five fishes were solitary in respective group in that day. Results are given as mean±SD. 
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According to feeding behavior observations, timidity was in average the most 
frequent behavior of sea bass juveniles in all groups during the three periods of 
the assay (Figure 6a). Since this pattern was observed in all five testing groups, 
exposure to FX did not exert any effects on the feeding behavior of sea bass 
juveniles. In average, the intake of food was always above 50 % in the five 
testing groups, and during the three periods of the assay (short and long 
exposure and recovery). During the assay the percentage of food intake by sea 
bass juveniles varied significantly between testing groups (F=3.28; p<0.05) and 
between periods of the assay (F=10.34; p<0.05). There was a trend to increase 
the food intake throughout time and in all groups food intake was always higher 
than in previous period (Figure 6b). On short period of exposure, food intake 
levels were low in groups exposed to 5 and 50 µg/ L of FX when compared to 
the other groups, nonetheless no significant differences were detected. On long 
period of exposure, there was a increase in food intake in all five testing groups, 
namely in the group exposed to 50 µg/L of FX. During the recovery period, the 
tendency of the previous period was also observed, with CtS and FX50 groups 
reaching the highest percentages of food intake. 
 
a) 
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Figure 6: Feeding results as: a) feeding behavior (Criteria used: 1 - indifference, 2 - timidity; and 3 - voracious); and 
b) food intake (in percentage) of juvenile sea bass of five testing groups during three periods of the assay (short, long 
and recovery). Results are given as mean ± SD. Legend: Ct - control; CtS - solvent control; FX0.5 - concentration of 
0.5 µg/L of FX; FX5 - concentration of 5 µg/L of FX; and FX50 - concentration of 50 µg/L of FX. Different letters 
denote significant differences (p<0.05) between groups. 
 
The raceway experiment showed that only 14 juveniles swam the 3 m 
distance of the raceway (Table II in Annex). Nonetheless, swimming velocity of 
sea bass juveniles was calculated with the few data obtained, and ranged from 
0.03 to 0.32 m/s in exposure period and 0.16 to 0.50 m/s in recovery period 
(Table 2). Also, during the first 15 days of the assay, juveniles tended to resist 
the counter current of the raceway and during this period, flow resistance was 
observed in all groups (Figure 7). Also, the majority of juveniles could resist for 
at least sixty seconds to the counter current (Figure 7). The frequency of 
individuals that swam and that presented flow resistance behavior are 
summarized in Table II in Annex. 
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Table 2: Swimming velocity results in m/s (mean ± SD). Results are distributed by two periods. Number (n) of fishes that 
swam in each period of time. 
  Period Swimming velocity n 
Ct 
Exposure 0.03 1 
Recovery 0.5 1 
CtS 
Exposure 0.13 1 
Recovery 0.21 ± 0.08 2 
FX0.5 
Exposure - - 
Recovery - - 
FX5 
Exposure 0.20 ± 0.15 6 
Recovery - - 
FX50 
Exposure 0.32 ± 0.26 2 
Recovery 0.16 1 
   
14 
 
 
Figure 7: Flow resistance in time (s) of the five testing groups for each day of observation. Results are given as mean 
± SD. Legend: Ct - control; CtS - solvent control; FX0.5 - concentration of 0.5 µg/L of FX; FX5 - concentration of 5 
µg/L of FX; and FX50 - concentration of 50 µg/L of FX. Results are given as mean± SD. 
 
Regarding to location of fishes in the aquarium, results showed no alterations 
to the typical behavior of the sea bass juveniles. The number of fishes located 
at the top of water column was always less than 25%, with an average of less 
than three fishes observed in all treatment groups and during the assay (Figure 
8a). In contrast, the location of fishes at the bottom of the aquarium revealed a 
different pattern, since in average, 3 to 5 fishes prefer the bottom of the 
aquarium (Figure 8b). This pattern maintained during the three periods of the 
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assay in all treatment groups. Preference for upper regions was not observed, 
so no anxiolytic effects of FX were observed on the position. However, 
scototaxis results showed a decrease in anxiety levels in fishes exposed to the 
three concentrations of FX, in contrast to control groups where the levels 
always above 60% (Figure 8c). From day 7 to the end of exposure period, the 
percentage of individuals with preference for the black compartment (anxiety) 
decreased in FX0.5, FX5 and F50. In the first day of recovery (day 21) levels of 
anxiety were still low, however by the end of the recovery period the percentage 
of individuals with preference for the black compartment on FX5 increases to 
initial levels (100%). Even low FX concentrations led to a decrease of anxiety in 
sea bass juveniles. 
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Figure 8: Anxiety results of sea bass juveniles as: preference for the top (a) and bottom (b) of the aquarium (Criteria 
used: 1 - less than three fishes; 2 - three to five fishes; and 3 - more than five fishes) for three periods of the assay; 
and c) scototaxis (in percentage). Results of a) and b) are given as mean ± SD and c) in frequency. Legend: Ct - 
control; CtS - solvent control; FX0.5 - concentration of 0.5 µg/L of FX; FX5 - concentration of 5 µg/L of FX; and FX50 - 
concentration of 50 µg/L of FX. 
 
4.2. Hepatosomatic index 
HSI varied between 2.27±0.93% after 21 days of assay, and 2.13±0.71% 
after seven days of recovery. HSI results did not varied significantly between 
groups (F=1.87; p>0.05) or between periods of exposure (F=0.65; p>0.05) 
(Figure 9), indicating the lack of effect of FX on the fish condition. 
 
Figure 9: HSI results of the five testing groups at the end of exposure period (day 21) and at the end of recovery 
period (day 28). Results are given as mean ± SD. Legend: Ct - control; CtS - solvent control; FX0.5 - concentration of 
0.5 µg/L of FX; FX5 - concentration of 5 µg/L of FX; and FX50 - concentration of 50 µg/L of FX. Different letters 
denote significant differences (p<0.05) between groups. 
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4.3. Brain gene expression 
The expression of the target genes sert, 5-ht3b and mao was assessed at 
day 21 and 28 (Figure 10). Two-way ANOVA detected significant differences 
between groups in different days (F=3.10; p<0.05) for gene sert mRNA 
transcription. A significant transcriptional increase in FX50 from day 21 to day 
28 was observed (Figure 10a). No significant differences were detected 
between groups (F=0.53; p>0.05) and in different days [F=0.41; p>0.05] in 
mRNA transcription of gene 5-ht3B. In fact, levels were stable from day 21 to 
day 28 (Figure 10b). For gene mao, no significant differences were detected 
between groups (F=0.58; p>0.05) in different days [F=1.16; p>0.05]. Again, 
transcription levels were approximately stable from day 21 to 28 (Figure 10c). 
 
 
a) 
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Figure 10: Results of target brain genes for last day of exposure (day 21) and the last day of recovery (day 28) for: a) 
gene sert; b) gene 5-ht3b; and c) gene mao. Results are given as mean ± SD. Legend: Ct - control; Ct S - solvent 
control; FX0.5 - concentration of 0.5 µg/L of FX; FX5 - concentration of 5 µg/L of FX; and FX50 - concentration of 50 
µg/L of FX. Different letters denote significant differences (p<0.05) between groups. 
 
5. Discussion 
This study aimed to evaluate the effects of three concentrations of 
antidepressant FX in European sea bass juveniles at several behavior levels 
(shoaling, position on the aquarium, feeding, swimming, anxiety and food 
intake) and also at the expression of target genes on brain (sert, 5ht-3b and 
mao). This estuarine and coastal species was chosen because is a potential 
target of this type of contaminants.  
 
 5.1. Behavior 
Shoaling results were very constant during the assay. In fact, during the 
three periods less than three fishes were solitary, indicating that exposure to FX 
did not altered the typical shoaling behavior of sea bass juveniles. Similar 
results were obtained by Ólsen et al. (2014) without differences in shoaling of 
endler guppy (Poecilia wingei) after the two periods of exposure to SSRI 
Citalopram. However Xie et al. (2015) observed that shoaling in crucian carp 
(Carassius carassius) decrease when SER concentrations (4.36, 21.3 and 116 
µg/ L) increased. Considering that sea bass juveniles tend to shoal 
(Vasconcelos et al., 2010) and since the number of solitary fishes were low and 
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constant during the assay, results indicate that FX had no influence in shoaling 
of this species. 
In general, juveniles responded timidly to the presence of food in the 
aquarium. From short to long period, more individuals started to have voracious 
behavior that continued to increase in the recovery period. Food intake results 
showed that this parameter varied largely during the assay, however there was 
a tendency to increase over the assay. At short period of time, food intake in 
fishes from the two highest concentrations of FX was lower than control groups. 
The increase of fishes with voracious behavior complement and confirm that 
during the assay there was a increase in food intake, however it is not 
completely in accordance with previous studies where anorexic effects of FX 
were observed. Low concentrations (at least ≤0.54 µg/ L) of FX have already 
been described as not causing alterations on food intake. Menningen et al. 
(2010) observed no significant differences in goldfish exposed to 0.54 µg/ L for 
a period of 28 days when compared to control group. When exposed to 0.12 µg/ 
L of SSRI SER, Eurasian perch (Perca fluviatilis) showed the same pattern, 
without feeding alterations when compared to control group. Our results showed 
the same pattern, indicating  that low concentrations of FX do not alter food 
intake of European sea bass. However, when exposed to higher concentrations 
of FX, fishes appear to have different responses to the antidepressant. 
Menningen et al. (2009) results showed a decrease of food intake exposed to 5 
µg/ L of FX for thirteen days. The lowest value of food intake observed was at 
day 9, and from day 9 to 13 there was a small increase. Menningen et al. (2010) 
observed that 54 µg/ L of FX decreased food intake in goldfish during 28 days 
of exposure, mainly after 8 days of exposure, continuing lower than control until 
the end of the assay. Our results for similar concentrations of 5 and 50 µg/ L of 
FX showed the same pattern as this two studies, however we cannot affirm that 
FX has anorexic effects in European sea bass juveniles due to no significant 
differences observed. 
Since the number of fish that swam during the essay was low it was not 
possible to assess the influence of FX in the swimming velocity of European 
sea bass. Prior to the experiments, during the preliminary tests (calibration of 
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the system) almost all fishes tested swam against the 6 L/m flow, not 
suggesting the difficulties experienced during the assay. Since individuals of 
Control group did not swim also, we exclude the hypothesis of FX as 
responsible for these results. Everything was done according to previous 
studies for swimming velocity (Gravato and Guilhermino, 2009; Almeida et al., 
2010; Almeida et al., 2012), with the exception of the water flow which is 
different from those used in these studies. Flow resistance was observed in 
European sea bass, however when exposed to a different contaminant, 
polycyclic aromatic hydrocarbons and during a period of 96 hours, where the 
increase of the concentration leaded to a decrease of flow resistance time 
(Almeida et al., 2012). Such pattern wasn't observed in the present study, 
however several fishes resisted the water flow in the raceway experiments. 
Since there was no change on the time of resistance with increase of FX 
concentration, results do not indicate any relation between FX exposure and 
flow resistance. Flow resistance may indicate that fishes were not in conditions 
to swim against the current. The number of fishes that resist the water current 
was higher than those who swam. Since flow resistance may indicate that 
fishes were not in conditions to swim, this could explain why the number of 
fishes that swam was low, however more tests should be made in order to 
complement our data and further investigate the effect of FX in the swimming 
velocity of fishes. Swimming capacity is very important in fish performance and 
survival (Almeida et al., 2010; Almeida et al. 2012) namely for a predator specie 
as European sea bass (Pickett and Pawson, 1994). Also, is determinant for a 
fish to capture prey, avoid other predators, reproduction, migrations and shoal 
(Weis et al., 2001). Alterations in the swimming capacity of mice (Lira et al., 
2003) and fish (Gaworecki and Klaine, 2008; Winder et al., 2011; Barry, 2013) 
have already been described, so it is important to evaluate if FX can also 
compromised swimming capacity in European sea bass juveniles. Alterations 
on swimming capacity can cause difficulties to individuals with repercussions on 
populations, especially during their first year, when mortality is high.  
Relatively to the anxiety results it was shown that the exposure of European 
sea bass juveniles to antidepressant FX can alter their anxiety. Regarding the 
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position in the aquarium, results showed that the number of fishes at the bottom 
was higher than in the top of the aquarium. Since this pattern was observed 
during the assay and also in control groups we can exclude any effect of FX on 
the preference for a position on the aquarium. Contrary to our results, previous 
studies showed anxiolytic effects of FX which leads to increased time that fishes 
spend in upper regions of the aquariums. Zebrafish exposed for 14 days to 100 
µg/ L of FX, increased the time spent in upper regions of the tank in comparison 
with control group (Egan et al., 2009). Gaworecki and Klane (2008) also 
observed the same tendency in hybrid striped bass, where individuals that were 
exposed to 150 µg/ L of FX preferred the top of the tank to the bottom or the 
center. Since the concentrations used in these two studies were superior to the 
present study, we cannot exclude the possibility that higher FX concentrations 
can affect the position in aquariums of European sea bass juveniles. Scototaxis 
results showed a decrease in anxiety levels. During the entire assay the 
percentage of individuals with preference for the black compartment of the 
aquarium (anxiety) was never lower than 60% in the control groups. However, 
during the period of exposure to FX there was a decrease of individuals with 
preference for the black compartment of the aquarium. Our results indicate that 
anxiety levels have decreased in exposed fish during the experimental period. 
Such pattern was particularly evident in fishes from the top concentration, since 
at the end of exposure period (21 days) no fish preferred the black 
compartment. Although this concentration is much higher than those found in 
the environment (Fent et al., 2006; Kreke and Dietrich, 2008; Silva et al., 2014), 
this result can predict negative consequences of a possible exposition of 
European sea bass juveniles to FX. Namely decrease of shelter search or 
decrease of fear against predators and therefore enhance the mortality during 
the first year, endangering the natural populations and their dynamics. During 
the recuperation period, the preference for the black compartment in the 
exposed fishes tended to return to initial levels, but at different rates. FX 
anxiolytic effects have already been reported for several species. Maximino et 
al. (2011) used scototaxis to evaluate the anxiety in zebrafish and acute FX 
effects were not observed, as white avoidance has not occurred, however after 
chronic exposure (2 weeks) anxiolytic effects were observed. These results are 
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in concordance with our results where anxiolytic effects were observed at the 
15th day. Also in zebrafish, who were exposed to 100 µg/ L during 14 days, a 
decrease in anxiety was observed when compared with control group (Egan et 
al., 2009). Valenti et al., (2012) also observed decrease of anxiety in fathead 
minnows after exposure to antidepressant SER (3, 10 and 30 µg/ L) for 28 days. 
In resume, the present results reinforce the anxiolytic effects of FX in fishes. 
 
5.2. Hepatosomatic index 
Liver is the major detoxification organ (Kime, 1998), so a altered liver can 
be a indicator of contamination (Pinkney et al., 2001; Sadekarpawar and Parikh, 
2013). Following such approach, the study monitored the evolution of HSI 
during the assay. After exposure period, HSI increase in comparison to control 
group. On recovery period there was a decrease of HSI in the three FX groups 
in comparison with control group where there was a increase. Other studies 
have already described the same pattern of HSI in fishes exposed to 
antidepressant FX. Menningen et al. (2010) results showed that HSI of goldfish 
increased when exposed to 0.54 and 54 µg/ L of FX when compared to control 
group. However no significant differences were detected during the assay and 
control solvent has the same pattern as the FX groups and therefore we cannot 
affirm that FX has altered this condition factor. 
5.2. Gene expression 
Sert is a transporter of 5-HT that is inhibited by SSRI like FX, increasing 
therefore the extracellular levels of 5-HT. During the assay, significant 
differences were detected in the expression of gene in fishes exposed to 50 µg/ 
L of FX. The expression of sert increased on the recovery period, after the 
contaminant was removed. FX can act in sert at short term, but alterations on 
gene expression appears after long time exposure (Kreke and Dietrich, 2008). 
On 21th day, sea bass juveniles exposed to 50 µg/ L of FX have no significant 
differences between the other groups, however when the antidepressant is 
removed there is a increase in the expression of this gene, so we can suppose 
that FX acted somehow on the transcription of sert. Few studies have 
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documented the effects of FX in the expression of serotonin transporters in 
fishes. Airhart et al. (2007) observed that 4.6 µM of FX had no effect on the 
expression of sert on zebrafish larvae (6 days post fertilization) brain (forebrain, 
midbrain and hindbrain), however a significant decrease of the expression was 
observed in the spinal cord. Gaworecki and Klaine (2008) observed a decrease 
in brain levels of 5-HT in hybrid striped bass after exposition to FX, which can 
indicates that 5-HT transporters in fishes can also respond to FX. Previously, 
studies in mammals have also showed effects of FX on gene sert. Neumaier et 
al. (1996) studied the effects of chronic exposure to FX on mRNA expression of 
sert in rat dorsal raphe nucleus. This specific area of the brain contains 
numerous fivers that connect to other regions of the brain, and therefore it is 
very important in the distribution of 5-HT by the brain, also there is a 
homologous region of brain in fishes called isthmus (Kreke and Dietrich, 2008). 
Animals were treated with FX, showed a decrease of sert mRNA levels, 
however after long exposure (plus 14 days) levels of sert increased to control 
groups levels, which may indicate a acute effect of FX on sert mRNA 
expression (Neumaier et al., 1996). Le Poul et al. (2000) results showed no 
differences in the expression of sert mRNA in rat brain (anterior raphe) exposed 
to 8 mg/ kg FX for 21 days. Benmansour et al. (1999) observed that SSRI 
paroxetine (10 mg/ kg) increased mRNA expression of sert in rat brain (dorsal 
raphe). The importance of gene sert in the modulation of several behaviors has 
been documented. Experiences with null mutant mice's for sert demonstrated 
that this individuals increased anxiety and reduced exploratory locomotion in the 
light/ dark exploration (Holmes et al., 2003) and the responses to different 
antidepressants (Holmes et al., 2002). Other results also in mice, showed 
latency to feed and more immobility in forced swim (Lira et al., 2003). Due to the 
conservation in vertebrates of target sites of antidepressants (Kreke and 
Dietrich, 2008) we can assume the importance of gene sert in the behavior of 
fishes. Since our results show anxiolytic effects of FX, we can suppose that this 
could be related to the modulation of SERT expression. 
Our results showed no significant differences in the expression of gene 5-
ht3B and maintained expression levels stable. 5-ht3B protein belongs to the 
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family of 5-ht3 receptors, wherein this family is the only in 5-HT receptors with 
ligand-gate ion channel as transduction pathway (Kreke and Dietrich, 2008). 
This protein is identified both on peripheral and CNS of humans and other 
mammals (Kreke and Dietrich, 2008; Bétri et al., 2011), however in fishes little 
is known about their presence and/or function in this organisms. Lucchelli et al. 
(1995) results showed in guinea pigs that FX inhibits 5-HT release from 5-ht3 
receptors in dorsal raphe, and that FX has moderate potency at central 5-ht3 
receptors. The inhibitory effects of FX on 5-ht3 receptors were also investigated 
by Fan (1994) with whole-cell patch-clamp technique, and for that it was used 
rat nodose ganglia. Results showed that 5-ht3 receptor is a possible acting site 
of FX, however it was observed that FX effects on the receptor may only have 
short-life action (Fan, 1994). More studies about this gene in fish brain should 
be made, in order to increase knowledge about the role of this gene in 
serotoninergic system of fishes. 
Again, no significant differences were observed in our results, towards to 
the expression of gene mao. Enzymes mao have catabolic action, and are 
responsible for degradation and recycle vesicular 5-HT (Kreke and Dietrich, 
2008). These enzymes have already been described in several fish species 
such as goldfish (Hall and Urueña, 1982), rainbow trout (Edwards et al., 1986; 
Nicotra and Senatori, 1989) and zebrafish (Setini et al., 2005). However, little is 
known about the effects of SSRIs in fish mao expression. Cusin et al. (2002) 
observed in humans that antidepressants paroxetine and fluvoxamine appears 
to have no major role in mao A. Mao in fishes share similarities with mao from 
mammals, especially with mao A (Kreke and Dietriech, 2008; Lillesaar et al., 
2011). Our results showed differences in expression of mao mRNA, however 
not significant and since this enzyme is not the main target of FX, we can 
expect that no problematic alterations occur after exposure of European sea 
bass to this antidepressant. Nonetheless, more studies should be made in order 
to assess the role of mao in fishes, since differences with mammals mao exists 
(Kreke and Dietrich, 2008). 
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6. Conclusions 
In conclusion, the present study showed that antidepressant FX can 
decrease the levels of anxiety in European sea bass juveniles, nonetheless FX 
haven't increase the preference for upper regions of the aquarium. Our results 
showed no influence of FX on shoaling. Also, anorectic effects of FX were not 
observed in any group during the assay, however food intake increased during 
the assay in all groups. The present study was not able to investigate the 
effects of FX on sea bass juveniles swimming velocity, since the number of 
fishes that swam through the raceway was reduced not allowing to have 
meaningful results, highlighting the need to perform further studies. No apparent 
effects on HSI levels were observed after the exposure to FX. 
The expression of sert has increased from day 21 to 28 after exposure to 50 
µg/ L of FX, which could be related to anxiolytic results observed in scototaxis 
tests. The expression of mRNA of 5-ht3B and mao suffered few alterations, 
indicating that no important alterations could occur after the exposure to FX.  
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Chapter 3. Final remarks 
The on growing use of antidepressants and the lack of appropriated 
methods to eliminate them from wastewaters, lead to the problem of 
ecosystems contamination. However, the investigation of the effects of 
antidepressants on aquatic organisms or the ecosystems is recent and 
therefore still need a more thorough collection of information. This study is part 
of a major study whose objectives were to evaluate the effects of 
antidepressants in European sea bass at several levels. There is no information 
in what regards the effects of the antidepressant FX in this species, however 
due to the conservation of target sites in vertebrates it was expected that similar 
effects to those already observed in other animals could also occur in our study.  
FX has already been described as capable of inducing alterations at several 
levels of the fish, such as behavioral and physiological changes. Indeed, our 
study was able to show some of these changes also in juvenile sea bass. For 
example, the decrease of anxiety that we observed was an example of the 
anxiolytic effects of FX. This decrease of anxiety can make juveniles less 
cautious to danger and can affect their search for shelter, especially in 
juveniles, where the mortality rate is high. Little is known about the effects of FX 
on gene expression, and our results showed that high concentrations of FX 
could alter the expression of gene sert, which is a pre synaptic serotonin 
transporter. sert protein has already been described as important to modulation 
of several behaviors (as anxiety and feeding) especially in mammals, so it is 
important to assess the regulation of the gene in fishes in order to assess 
possible changes after exposure to FX. 
It was not possible to evaluate if FX can alter the swimming velocity of 
European sea bass juveniles. Swimming capacity is very important for a fish, 
namely a predator species, to be able capture prey or avoid predators and 
migrations. If this capacity is compromised, this could bring serious problems to 
the population dynamics. Even if this important point of the study was not able 
to be study, it is important that more tests should be made to assess if this 
behavior could be compromised or not by the exposition to antidepressant FX. 
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Further studies about the effects of FX and other antidepressants on fishes 
should be made in the future, not only at behavior level but also at 
physiological. Also, more tests about target FX genes, namely in fishes should 
be made in order to increase knowledge about this area and to assess effects 
that could occur after exposure to antidepressants. 
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Annex 
Tables 
Table I: Sheet used to register the behavior parameters. 
 
Analisys 
Data Morning (Hour) Afternoon (Hour) 
Parameters             
Solitary             
Top             
Bottom             
Notes 
            
Feeding 
            
 
 
Table II: Sheet with results of swimming tests. Legend: * time (s) that took to swim the 3 m raceway;  ** time (s) resisting 
water flow; - Individuals that didn't swam. Frequency of individuals that swam (f(S)) and individuals that exhibit flow 
resistance (f(R)) was also calculated. 
Aquarium 5 (Ct) 
Fish/ Day 1 3 7 15 21 28 
1 - - 60** - - - 
2 - - - - - - 
3 - 40** 22** - - - 
4 - - - - - 6* 
5 - - - 60**     
6 - 1.27* - 60**     
7 - 30** - -     
8 - 60** - -     
f (S) 0% 13% 0% 0% 0% 25% 
f (R) 0% 38% 25% 25% 0% 0% 
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Aquarium 8 (CtS) 
Fish/ Day 1 3 7 15 21 28 
1 60** - - - 20* 43** 
2 - - - 60** - - 
3 60** 60** - 60** - 11* 
4 60** 60** 60** 24* - - 
5 - 60** 60** -     
6 - - - 60**     
7 60** 60** - -     
8 - 60** 60** -     
f (S) 0% 0% 0% 13% 25% 25% 
f (R) 50% 63% 38% 38% 0% 25% 
       
       Aquarium 14 (FX0.5) 
Fish/ Day 1 3 7 15 21 28 
1 - - - - - - 
2 - - - - - - 
3 60** - - - - - 
4 - - - - - - 
5 - - - -     
6 - - - -     
7 - - - -     
8 - - - -     
f (S) 0% 0% 0% 0% 0% 0% 
f (R) 13% 0% 0% 0% 0% 0% 
       
       Aquarium 13 (FX5) 
Fish/ Day 1 3 7 15 21 28 
1 - - - - - - 
2 - - 40* - - 60** 
3 - - 20** - - 60** 
4 60** 60** 60** 20* - - 
5 - 30** - 17*     
6 20* - 60** -     
7 - - 60** 6*     
8 60** - - 24*     
f (S) 13% 0% 13% 50% 0% 0% 
f (R) 25% 25% 50% 0% 0% 50% 
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       Aquarium 2 (FX50) 
Fish/ Day 1 3 7 15 21 28 
1 - - - - - - 
2 - - - - - 19* 
3 - - - - - - 
4 - - 60** 22* - - 
5 60** - 60** -     
6 - - - 6*     
7 60** - - -     
8 - - 60** -     
f (S) 0% 0% 0% 25% 0% 25% 
f (R) 25% 0% 38% 0% 0% 0% 
 
Figures 
 
 
Figure I: Raceway device used for the swimming tests. 
 
 
 
Figure II: Aquarium (with black and white compartment) used for anxiety tests. 
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Protocols 
Protocol I 
Note: Always start the process from the control group to the highest 
concentration of FX. 
1. Collect the animal and put him in a small aquarium for a short time, for 
cleaning  the animal; 
2. Take the animal from the aquarium and put him carefully in the raceway 
device; 
3. Start to count when the animal reach the starting point (0 meters) ; 
4. Stop the count when the animal reach the finish point (3 meters), and register 
time he toke to reach it; 
5. If the animal doesn't swim but resist to the water flow, time he spend resisting 
was also registed 
6. Take the animal from the raceway device and put him again in the test 
aquarium; 
7. Repeat the procedure to the other fishes in each aquarium. 
 
Protocol II 
Note: Always start the process from the control group to the highest 
concentration of FX. 
1. Put the sliding doors in the scototaxis aquarium; 
2. Collect the animal and put him in a small aquarium for a short time, for 
cleaning  the animal; 
3. Take the animal from the aquarium and put him carefully in the central zone 
of the aquarium; 
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4. After a short period of acclimatization, remove the sliding doors at the same 
time; 
5. Wait until the fish choose a zone of the aquarium and stabilize, and register 
his preference; 
6. Take the animal from the aquarium and put him again in the test aquarium; 
 7. Repeat the procedure to the other fishes in each aquarium. 
 
 
